Question

Which patient would be at highest risk for developing oral candidiasis?

a. A 74-yr-old patient who has vitamin B and C deficiencies
b. A 22-yr-old patient who smokes 2 packs of cigarettes per day
c. A 32-yr-old patient who is receiving ciprofloxacin for 3 weeks
d. A 58-yr-old patient who is receiving amphotericin B for 2 days

Answer 1

The patient who would be at the highest risk for developing oral candidiasis is d. A 58-yr-old patient who is receiving amphotericin B for 2 days.

Step-by-step explanation:

Amphotericin B is an antifungal medication known to disrupt the cell membrane of fungi, including Candida species that can cause oral candidiasis. Patients receiving amphotericin B are at an increased risk of developing oral candidiasis due to the medication's impact on the normal flora of the mouth, allowing for the overgrowth of Candida.

Monitoring for signs and symptoms of oral candidiasis is crucial in patients undergoing treatment with amphotericin B to provide timely intervention and prevent the worsening of the fungal infection. The risk is higher in patients receiving amphotericin B for a more extended duration.

While other factors such as vitamin deficiencies, smoking, and antibiotic use (as in option c) can contribute to oral candidiasis risk, the direct antifungal action of amphotericin B makes patients on this medication more susceptible. This underscores the importance of tailored care and vigilant monitoring for patients receiving medications with known side effects on oral health.